Zhang M - Search Results

1

Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.

Chakravarti A, Zhai GG, Zhang M, Malhotra R, Latham DE, Delaney MA, Robe P, Nestler U, Song Q, Loeffler J. Chakravarti A, et al. Among authors: zhang m. Oncogene. 2004 Sep 30;23(45):7494-506. doi: 10.1038/sj.onc.1208049. Oncogene. 2004. PMID: 15326475

2

Survivin mediates resistance to antiandrogen therapy in prostate cancer.

Zhang M, Latham DE, Delaney MA, Chakravarti A. Zhang M, et al. Oncogene. 2005 Apr 7;24(15):2474-82. doi: 10.1038/sj.onc.1208490. Oncogene. 2005. PMID: 15735703

3

Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.

Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A. Zhang M, et al. Prostate. 2005 Aug 1;64(3):293-302. doi: 10.1002/pros.20263. Prostate. 2005. PMID: 15754318

4

Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway.

Zhai GG, Malhotra R, Delaney M, Latham D, Nestler U, Zhang M, Mukherjee N, Song Q, Robe P, Chakravarti A. Zhai GG, et al. Among authors: zhang m. J Neurooncol. 2006 Feb;76(3):227-37. doi: 10.1007/s11060-005-6499-4. J Neurooncol. 2006. PMID: 16200346

5

Novel radiation-enhancing agents in malignant gliomas.

Zhang M, Chakravarti A. Zhang M, et al. Semin Radiat Oncol. 2006 Jan;16(1):29-37. doi: 10.1016/j.semradonc.2005.08.004. Semin Radiat Oncol. 2006. PMID: 16378904 Review.

6

Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.

El-Jawahri A, Patel D, Zhang M, Mladkova N, Chakravarti A. El-Jawahri A, et al. Among authors: zhang m. Mol Diagn Ther. 2008;12(4):199-208. doi: 10.1007/BF03256285. Mol Diagn Ther. 2008. PMID: 18652516 Review.

7

Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.

Zhang M, Ho A, Hammond EH, Suzuki Y, Bermudez RS, Lee RJ, Pilepich M, Shipley WU, Sandler H, Khor LY, Pollack A, Chakravarti A. Zhang M, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1033-42. doi: 10.1016/j.ijrobp.2008.06.1489. Epub 2008 Oct 30. Int J Radiat Oncol Biol Phys. 2009. PMID: 18977097 Free PMC article.

8

Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells.

Zhang M, Siedow M, Saia G, Chakravarti A. Zhang M, et al. Prostate. 2010 Jun 1;70(8):807-16. doi: 10.1002/pros.21114. Prostate. 2010. PMID: 20054820 Free PMC article.

9

Survivin is a potential mediator of prostate cancer metastasis.

Zhang M, Coen JJ, Suzuki Y, Siedow MR, Niemierko A, Khor LY, Pollack A, Zhang Y, Zietman AL, Shipley WU, Chakravarti A. Zhang M, et al. Among authors: zhang y. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1095-103. doi: 10.1016/j.ijrobp.2009.09.007. Epub 2010 Mar 16. Int J Radiat Oncol Biol Phys. 2010. PMID: 20231071 Free PMC article.

10

Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.

Chakravarti A, DeSilvio M, Zhang M, Grignon D, Rosenthal S, Asbell SO, Hanks G, Sandler HM, Khor LY, Pollack A, Shipley W; Radiation Therapy Oncology Group. Chakravarti A, et al. Among authors: zhang m. J Clin Oncol. 2007 Jul 20;25(21):3082-9. doi: 10.1200/JCO.2006.08.4152. J Clin Oncol. 2007. PMID: 17634487 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62,487 results

Search Page

Filters